Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem–Resistant Acinetobacter baumannii

Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates

(2021) Julalak C. Ontong et al.   PLoS One

In Vitro Activity of Fosfomycin in Double and Triple Combinations with Imipenem, Ciprofloxacin and Tobramycin Against Multidrug-Resistant Escherichia coli

(2020) Wael Mohamed Abu El-Wafa et al.   CURRENT MICROBIOLOGY

In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa

(2020) Gabriel T Cuba et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and/or NDM-producing Klebsiella pneumoniae

(2020) Buket Erturk Sengel et al.   JOURNAL OF CHEMOTHERAPY

How antibiotics work together: molecular mechanisms behind combination therapy

(2020) Geraldine J Sullivan et al.   CURRENT OPINION IN MICROBIOLOGY

In Vitro Activity of Fosfomycin and Nitrofurantoin Against Contemporary Enterobacterales Pathogens Isolated from Indian Tertiary Care Hospitals

(2020) Rajesh Chavan et al.   Microbial Drug Resistance

Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study

(2020) Alessandro Russo et al.   Infectious Diseases and Therapy

In vitro synergistic activity of fosfomycin in combination with other antimicrobial agents against carbapenem-resistant Klebsiella pneumoniae isolated from patients in a hospital in Thailand

(2020) Arnon Chukamnerd et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria

(2019) Ronald Domalaon et al.   Frontiers in Microbiology

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

(2019) Nam Su Ku et al.   Scientific Reports

Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction

(2019) Anthony R. M. Coates et al.   Expert Review of Anti-Infective Therapy

The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis

(2018) Cristina García-de-la-Mària et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada

(2018) George G. Zhanel et al.   Canadian Journal of Infectious Diseases & Medical Microbiology

In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates

(2018) Uthaibhorn Singkham-in et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and Gram-negative bacteria

(2018) Sophie A Baron et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

OUP accepted manuscript

(2018)   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections

(2018) Oriana Simonetti et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance

(2018) Xuejie Xu et al.   Scientific Reports

In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae

(2018) Wei Yu et al.   Infection and Drug Resistance

Fosfomycin: mechanisms and the increasing prevalence of resistance

(2018) Mina Aghamali et al.   JOURNAL OF MEDICAL MICROBIOLOGY

In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran

(2018) Raziyeh Kheshti et al.   Infection and Drug Resistance

Compatibility of fosfomycin with different commercial peritoneal dialysis solutions

(2017) M. Kussmann et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol

(2017) Wen-juan Wei et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Fosfomycin: Mechanism and Resistance

(2017) Lynn L. Silver   Cold Spring Harbor Perspectives in Medicine

Intravenous Fosfomycin (ZTI-01) for the Treatment of Complicated Urinary Tract Infections (cUTI) Including Acute Pyelonephritis (AP): Results from a Multi-center, Randomized, Double-Blind Phase 2/3 Study in Hospitalized Adults (ZEUS)

(2017) Keith S Kaye et al.   Open Forum Infectious Diseases

Fosfomycin

(2016) Matthew E. Falagas et al.   CLINICAL MICROBIOLOGY REVIEWS

Fosfomycin resistance inAcinetobacter baumanniiis mediated by efflux through a major facilitator superfamily (MFS) transporter—AbaF

(2016) Atin Sharma et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Holarrhena antidysentericaExtract and Its Steroidal Alkaloid, Conessine, as Resistance-Modifying Agents Against Extensively Drug-ResistantAcinetobacter baumannii

(2016) Thanyaluck Siriyong et al.   Microbial Drug Resistance

Aminoglycosides: An Overview

(2016) Kevin M. Krause et al.   Cold Spring Harbor Perspectives in Medicine

Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance Mechanisms

(2016) Gleice Cristina Leite et al.   PLoS One

Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy

(2015) Bala Kishan Gorityala et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Reviving old antibiotics

(2015) Ursula Theuretzbacher et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Potentiation Effects of Amikacin and Fosfomycin against Selected Amikacin-Nonsusceptible Gram-Negative Respiratory Tract Pathogens

(2014) A. Bruce Montgomery et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii

(2014) Sarunyou Chusri et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates

(2014) Abdollah Ardebili et al.   Jundishapur Journal of Microbiology

Susceptibility of Multiresistant Gram-Negative Bacteria to Fosfomycin and Performance of Different Susceptibility Testing Methods

(2013) L. V. Perdigão-Neto et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combination approaches to combat multidrug-resistant bacteria

(2013) Roberta J. Worthington et al.   TRENDS IN BIOTECHNOLOGY

Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods

(2011) Ching-Lan Lu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Low Tigecycline Concentrations in the Cerebrospinal Fluid of a Neutropenic Patient with Inflamed Meninges

(2010) Claudia Lengerke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa

(2010) Qin Lu et al.   INTENSIVE CARE MEDICINE

Penetration of Colistin into Cerebrospinal Fluid

(2009) S. L. Markantonis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Brain Penetration of Colistin in Mice Assessed by a Novel High-Performance Liquid Chromatographic Technique

(2009) L. Jin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections

(2008) Matthew E. Falagas et al.   CLINICAL INFECTIOUS DISEASES

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study

(2008) Nikolaos Markou et al.   CLINICAL THERAPEUTICS